The University of Chicago Header Logo

Connection

Renslow Sherer to Drug Therapy, Combination

This is a "connection" page, showing publications Renslow Sherer has written about Drug Therapy, Combination.
Connection Strength

0.214
  1. Darunavir in the treatment of HIV-1 infection: a viewpoint by Renslow Sherer. Drugs. 2007; 67(18):2802-3.
    View in: PubMed
    Score: 0.055
  2. The importance of potency and durability in HIV patient antiretroviral therapy preferences: a telephone survey. AIDS Patient Care STDS. 2005 Dec; 19(12):794-802.
    View in: PubMed
    Score: 0.051
  3. Antiretroviral therapy 2002: old and new paradigms. J Int Assoc Physicians AIDS Care (Chic). 2002 Oct-Dec; 1(4):121-30.
    View in: PubMed
    Score: 0.041
  4. Current antiretroviral therapy and its impact on human immunodeficiency virus-related wasting. Semin Oncol. 1998 Apr; 25(2 Suppl 6):92-7.
    View in: PubMed
    Score: 0.030
  5. Delta in the real world. Lancet. 1996 Aug 03; 348(9023):278-9.
    View in: PubMed
    Score: 0.027
  6. Baseline HIV-1 RNA level and CD4 cell count predict time to loss of virologic response to nelfinavir, but not lopinavir/ritonavir, in antiretroviral therapy-naive patients. J Infect Dis. 2004 Jul 15; 190(2):280-4.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.